Related by context. All words. (Click for frequent words.) 64 AERAS-#/Crucell Ad# 63 TBC M4 62 Vaxfectin 61 VitiGam TM 61 Zemplar Capsules 60 TBC# 60 Tolamba 60 TransVax ™ 60 ChronVac C R 59 Vacc 4x 59 HQK 59 HEPLISAV TM 59 Pertuzumab 59 CBLC# 59 MenACWY 59 investigational hepatitis B 58 plasmid DNA vaccine 58 Anthim 58 acyclovir Lauriad R 58 Lovaxin C 58 ChronVac C ® 58 recombinant hepatitis B 58 riociguat 58 PENNVAX B 58 MVA#A 58 Japanese Encephalitis vaccine 58 OncoVex 58 TriGrid 57 preclinical efficacy 57 CRLX# 57 CMV vaccine 57 Synflorix 57 VivaGel TM 57 CERVARIX 57 ChimeriVax JE 57 Twinrix 57 novel therapeutic antibodies 57 dose intramuscular 57 Chimigen TM 57 Multimeric 57 GeoVax DNA 57 valent pneumococcal conjugate vaccine 57 Pandemic Flu Vaccine 57 Phase #/#a 57 Phase Ib clinical 57 LC#m# 57 TransVax 57 Vaxfectin R formulated 56 synDNA TM 56 vivo preclinical 56 Diamyd ® 56 TB Vaccine 56 Vaxfectin TM formulated 56 Merck Suspends Lobbying 56 CYT# NicQb 56 GeoVax vaccine 56 ROTARIX 56 trivalent influenza vaccine 56 Mosquirix 56 FluINsure 56 StemEx R 56 Adjuvanted 56 rPA anthrax vaccine 56 immunotherapeutic approaches 56 cyclophilin inhibitors 56 Phase 2b clinical trials 56 randomized multicenter trial 56 budesonide foam 56 therapeutic monoclonal antibody 56 AFFITOME R 56 Archexin 56 ToleroMune 56 preclinically 56 IMVAMUNE ® 56 oral picoplatin 56 PREVENAR 56 CEQ# 56 Vicriviroc 56 NP2 Enkephalin 55 phase Ib 55 GRNVAC1 55 PSMA ADC 55 tramiprosate Alzhemed TM 55 BrachySil 55 dimebon latrepirdine 55 VIR# 55 FLU v 55 REMUNE R 55 TOCOSOL Camptothecin 55 Phase Ib II 55 Mipomersen 55 phase IIa 55 elacytarabine 55 phase IIa clinical 55 PROSTVAC TM 55 olaparib 55 Universal Flu Vaccine 55 Microbicide 55 HEPLISAV TM hepatitis B 55 ProSavin 55 GLP toxicology studies 55 Muraglitazar 55 HuMax CD#b 55 Phase 2a clinical trials 55 Toxoid 55 Vaxfectin TM 55 Prodarsan 55 Heplisav 55 galiximab 55 ALK inhibitors 55 NSABP C 55 Inovio DNA 55 MAGE A3 ASCI 55 OncoVEX GM CSF 54 YONDELIS 54 Zoraxel 54 Aganocide ® 54 Tykerb lapatinib 54 VAX# 54 HBV vaccine 54 Transgene therapeutic 54 Angiocept 54 Diamyd r 54 OMP #M# 54 tremelimumab 54 Phase 1a clinical 54 ganetespib 54 OraQuick ® 54 Intercell Japanese Encephalitis 54 trastuzumab DM1 T DM1 54 serogroup B 54 HPTN 54 RNAi Therapeutic 54 live attenuated vaccines 54 HEPLISAV ™ 54 inecalcitol 54 reactogenicity 54 intradermal vaccine 54 midstage clinical 54 OncoVEX 54 Prostate AdenoCarcinoma Treatment 54 maturation inhibition 54 midstage trials 54 MF# adjuvanted 54 drug GLPG# 54 CCR5 inhibitor 54 includes TOLAMBA TM 54 motesanib 54 Urocidin 54 Cethromycin 54 designated HVTN 54 oral prodrug 54 bacillus Calmette Guerin BCG 54 Elocalcitol 54 CHAMPION PCI 54 ALVAC HIV 54 novel VDA molecule 54 Phase Ia 54 Aplidin 54 Phase 1b clinical trials 54 Tocosol Paclitaxel 54 SUCCEED trial 54 Bacillus Calmette Guerin 54 volociximab 54 subcutaneous PRO 54 paclitaxel poliglumex 54 Neuvenge 54 systemic RNAi 54 Hiberix 54 Aidsvax 54 postexposure prophylaxis 54 CRD5 53 Alzhemed TM 53 Malaria Vaccine 53 ORMD 53 prepandemic 53 VLP influenza 53 Phase #b/#a 53 OvaRex ® MAb 53 ASCEND HF 53 virosome 53 Phase IIIb clinical 53 Modified Vaccinia Ankara MVA 53 vemurafenib 53 resminostat 53 Vaccine Protects Against 53 Anticancer Drug 53 Reolysin 53 Omapro 53 TroVax 53 Allovectin 7 R 53 Aurora kinase inhibitor 53 Elagolix 53 pharmacokinetic PK study 53 purine nucleoside phosphorylase PNP 53 OvaRex R 53 Neo Kidney Augment ™ 53 immatics 53 Erimos 53 tetravalent vaccine 53 Rotavirus Vaccine 53 XL# SAR# 53 GAMMAGARD 53 HIV coinfected 53 metabolite identification 53 HCV protease inhibitors 53 DXL# 53 rxRNA 53 Phase Ib IIa 53 trastuzumab DM1 53 Virological 53 DEB# 53 Nasal spray flu 53 KINRIX 53 RPL# 53 ONCONASE R 53 EchoCRT 53 Canvaxin 53 GLP toxicology 53 afamelanotide 53 DCVax 53 ruxolitinib 53 VLP vaccine candidate 53 Phase IIa trial 53 IIa clinical 53 oocyte cryopreservation 53 Engerix B 53 valent pneumococcal 53 NVA# 53 phase IIb clinical 53 Onconase 53 Panzem 52 serological testing 52 SUTENT ® 52 virotherapy 52 Vertex hepatitis C 52 TOLAMBA 52 Aptivus ® 52 Provenge prostate cancer 52 BRIM3 52 4CMenB 52 NO# [002] 52 Phase III TRIST 52 cellulose sulphate 52 GLPG# 52 maximally tolerated dose 52 PANVAC VF 52 Aryplase 52 torezolid phosphate 52 Trovax 52 Avian Influenza Vaccine 52 Phase 2a trial 52 Bilive TM 52 Sutent sunitinib 52 alvespimycin 52 FluChip 52 mSEPT9 biomarker 52 H#N# Influenza Vaccine 52 Aptivus R 52 cynomolgus macaques 52 Oncotype DX colon cancer 52 phase IIb study 52 BRAF inhibitor 52 Dr. Vitetta 52 Tamiflu Relenza 52 Phase 1b trial 52 Vaginal gel 52 Exherin TM 52 potentially treat nephropathic 52 Tarvacin Anti Cancer 52 Cytolin ® 52 phase Ib clinical 52 VNP#M 52 live attenuated intranasal 52 neratinib 52 BACcel 52 phase IIb III 52 phase IIb 52 canakinumab 52 ReN# 52 tanespimycin 52 CINQUIL 52 multicenter Phase III 52 pharmacokinetic characteristics 52 VersaFilm 52 ToGA 52 pivotal bioequivalence 52 Varicella chicken pox 52 OvaRex 52 IIa Clinical Trial 52 RhuDex 52 Influenza Vaccine 52 retapamulin 52 bavituximab monotherapy trial 52 BLA filing 52 candidate REP# 52 ProLindac 52 attenuated vaccine 52 recurrent glioma 52 experimental antibiotic Trovan 52 Bacillus Calmette Guerin BCG 52 ENESTnd 52 number NCT# ClinicalTrials.gov 52 vaccine LAIV 52 demonstrated antitumor activity 52 seasonal influenza VLP vaccine 52 Asentar 52 Xelox 52 MVA BN 52 candidate CRLX# 52 MenB 52 dose escalation phase 52 bioequivalence studies 52 EC Cysteamine 52 methylation markers 52 pertuzumab 52 idiotype vaccines 52 masitinib 52 MEK inhibitors 52 SparVax 52 GeoVax HIV AIDS 52 Sanaria vaccine 52 Saxagliptin 52 VIRUSMAX TM 52 Lisofylline LSF 52 OLYMPIA registry 52 clinical trials Archexin 52 Motavizumab 52 confirmatory clinical 52 ACE BioSciences 52 PCR Polymerase Chain Reaction 52 Fodosine 52 cetrorelix pamoate 52 OvaRex MAb 52 Pagoclone 51 Exelixis XL# 51 trivalent seasonal flu 51 GSK# [002] 51 adjuvanted H#N# 51 inactivated influenza vaccine 51 Septin9 51 thorough QT 51 semi synthetic lipoglycopeptide 51 Cardio Vascu Grow 51 Vaccine Trials 51 Tdap tetanus diphtheria pertussis 51 ADVANCE PD 51 ularitide 51 RapidChek SELECT 51 LCP AtorFen 51 coli O# 51 LungSign TM 51 Phase IIIb study 51 IDI MRSA 51 oral rotavirus vaccine 51 vaginal microbicide 51 phase IIIb 51 conjugate vaccines 51 pertussis vaccines 51 Corus CAD 51 injectable interferon 51 lomitapide 51 CCR5 antagonist 51 bOPV 51 Lung Cancer Drug 51 Spartan RX CYP#C# 51 Gastrointestinal Stromal Tumors 51 HemoGenix 51 Ushercell 51 bivalent vaccine 51 Respiratory Syncytial Virus RSV 51 multicenter Phase II 51 tolevamer 51 Lupus Drug 51 Phase 1b clinical 51 MitoQ 51 Confirmatory 51 Phase IIb clinical trials 51 biomarker discovery validation 51 aleglitazar 51 adjuvanted vaccines 51 Valtropin 51 Prolastin R 51 Pre RELAX AHF 51 MF# adjuvanted vaccine 51 Oglemilast 51 Agriflu 51 AVADO 51 alum adjuvanted 51 translational genomics 51 PF # [002] 51 Artificial pancreas 51 canagliflozin 51 Arimoclomol 51 Phase lll 51 PORxin TM 51 conserved antigens NP 51 cannabinor 51 UPLYSO 51 intradermal injection 51 Bacille Calmette Guerin 51 Onalta ™ 51 Onyx Pharmaceuticals Announces 51 NSABP B 51 LHRH antagonist 51 ABSORB clinical 51 docetaxel Taxotere ® 51 refractory prostate cancer 51 oral rivaroxaban 51 WX UK1 51 Novartis MenB vaccine 51 recurrent metastatic 51 CVBT #H 51 Prostate Cancer Vaccine 51 ataluren 51 Phase III Clinical Trials 51 NASDAQ INFI 51 Vaccine Prevents 51 CALGB 51 clinical trials SGN 51 TQT studies 51 NNRTI resistant virus 51 PrevOnco 51 Randomized controlled 51 LungAlert TM 51 molecular diagnostic assay 51 7 valent pneumococcal 51 optimal dosing 51 C conjugate vaccine 51 GALNS 51 ENDEAVOR III 51 Shows Efficacy 51 BNC# 51 Phage Pharmaceuticals 51 Lung Cancer Vaccine 51 MEND CABG 51 bioequivalency 51 Trastuzumab DM1 51 VaxGen AIDSVAX 51 Phase Ib clinical trials 51 nevirapine regimen 51 TASKi3 51 ragweed allergy immunotherapeutic 51 PC Detect SM 51 evaluating mipomersen 51 Pulminiq 51 vitro allergy 50 treating enlarged prostates 50 treat premature ejaculation 50 Cancer Vaccines 50 Biojector ® 50 Phase #b/#a clinical 50 HPV Human Papilloma 50 inactivated poliovirus 50 Havrix 50 Exelixis compounds 50 Cloretazine ® 50 inhibit metastasis 50 phase IIb trial 50 Pimavanserin 50 WHO prequalification 50 Vaccine Trial 50 chickenpox varicella 50 novel L DOS# 50 relapsing remitting MS RRMS 50 molecular assays 50 ALSYMPCA 50 clinical pharmacology studies 50 oral deforolimus 50 rALLy trial 50 ICH guidelines 50 Polysaccharide Diphtheria Toxoid Conjugate 50 rALLy clinical trial 50 GSK Cervarix 50 GlaxoSmithKline Rotarix 50 eliglustat tartrate 50 viral kinetic 50 mSEPT9 50 virology immunology 50 CytoFabTM 50 include ColorectAlert TM 50 ORAL Sync 50 lenalidomide Revlimid R 50 Lupuzor 50 Agress TM 50 HRIG 50 XP #L 50 Array CGH 50 cancer immunotherapies 50 EMPHASIS HF trial 50 Delcath Phase III 50 VentiRx 50 DASISION 50 NADiA 50 MyVax 50 Inovio electroporation 50 VEGF inhibitor 50 EliA 50 Allovectin 7 ® 50 Phase #b/#a trial 50 Cardioxyl 50 multiplex assays 50 Acellular Pertussis Vaccine Adsorbed 50 Crizotinib 50 non adjuvanted vaccines 50 BGM Galectin 3 50 Anticalin 50 A/H#N# pandemic influenza 50 LymphoStat B TM 50 eosinophilic asthma 50 pentavalent rotavirus vaccine 50 Prednisporin TM 50 MassARRAY platform 50 multicentre randomized 50 conjugate vaccine 50 Pentavalent 50 intranasal influenza 50 Cogane 50 hepatitis B measles mumps 50 anticoagulant reversing agent 50 davunetide intranasal AL 50 TAXUS VI 50 Systemic Delivery 50 Immunotherapies 50 monovalent vaccine 50 ELISpot 50 ACOSOG Z# 50 rALLy 50 molecularly targeted therapies 50 novel chimeric natriuretic 50 Varicella chickenpox 50 meningococcal vaccines 50 dose escalation clinical 50 generation PNP inhibitor 50 trivalent inactivated influenza 50 mapatumumab 50 EGS# 50 Therapeutic Vaccines 50 APEX PD 50 ACIP recommendation 50 OvPlex 50 INSTI 50 basal insulin analogue 50 Amoxicillin PULSYS Phase III 50 modified vaccinia Ankara 50 Phase IIA 50 Epanova 50 efficacy 50 Phase III registrational 50 Motesanib 50 randomized multicenter Phase III 50 RNAi Therapeutics 50 blinded randomized placebo controlled 50 Phase #/#a clinical 50 Pediarix 50 Preclinical Data 50 CB2 selective receptor agonist 50 forodesine hydrochloride 50 inactivated vaccine 50 oral anticancer 50 Chimigen 50 MenACWY CRM 50 Alequel 50 Stapled Peptide 50 Phase IIa clinical 50 TEAM TSAT 50 Phase 2a preventative 50 Phase IIa trials 50 ABSORB trial 50 seliciclib CYC# 50 Vectibix panitumumab 50 Dacogen injection 50 pharmacokinetic studies 50 Confirmatory testing 50 midstage clinical trial 50 multicentre study 49 Cytolin R 49 detect XMRV 49 vitro molecular diagnostic 49 midstage clinical trials 49 Companion Diagnostic 49 assessing T DM1 49 haematological cancers 49 MeNZB 49 biomarker validation 49 CytoFab 49 albiglutide 49 sporicidal product 49 Pancreate 49 HGS# 49 HBsAg 49 MMR Measles Mumps Rubella 49 RECALL VAX TM 49 Alequel ™ 49 PCV# 49 Cardiac Markers 49 Phase Ib 49 DCVax Brain 49 Liposomal Grb 2 49 NanoStat 49 immunochemical fecal occult 49 SPIRIT IV 49 randomized controlled Phase 49 oral ridaforolimus 49 LibiGel Phase III 49 Guanilib 49 cellulose sulfate 49 Rotavirus vaccine 49 Telcyta 49 SuperAntibody 49 Xpert MTB RIF 49 postexposure 49 blood clot preventer 49 M2e 49 genotoxicity 49 Drug Shows Promise 49 measles mumps rubella varicella 49 multicenter clinical 49 Renal Cancer 49 HVTN 49 GVAX 49 E2F Decoy 49 bardoxolone 49 diphtheria tetanus pertussis vaccine 49 PREVNAR 49 RNAi therapeutic targeting PCSK9 49 AttoSense 49 TELCYTA 49 Phase 1a 49 unadjuvanted vaccines 49 live attenuated influenza 49 fosbretabulin 49 Charlesson 49 rotavirus vaccines 49 monoclonal antibody therapies 49 Avian Flu Vaccine 49 HandiLab 49 Corlux 49 HCV antiviral 49 Pollinex Quattro 49 Phase III randomized controlled 49 inactivated influenza 49 chemopreventive agents 49 SMT C# 49 vaccine Synflorix 49 axitinib 49 dirucotide MBP# 49 NIBSC 49 Nucleic Acid Testing 49 TransMID 49 Novel Therapeutic 49 randomized crossover 49 fidaxomicin Phase 3 49 serologic 49 Eniluracil 49 hepatitis B vaccine Heplisav 49 CellCentric 49 optimal dosing regimens 49 investigational protease inhibitor 49 chlamydial 49 SEPET TM 49 Lipoxen 49 adjuvant colon cancer 49 ganaxolone 49 Pivotal Trial 49 Trial Initiative LSTI 49 iPrEx 49 PCV7 vaccine 49 Xpert EV 49 Isis antisense 49 EXPLORE Xa 49 Raptiva ® 49 Merck RotaTeq 49 treatment naive genotype 49 HPV Human Papillomavirus 49 Shows Promising 49 Cervista HPV HR 49 QuantiFERON TB Gold 49 KRN# 49 parasitological 49 Measles Mumps Rubella MMR 49 Thorough QT 49 registrational Phase 49 ISEL 49 Dendreon Provenge 49 pipeline GlycoPEG GCSF 49 Atu# 49 intravenous iclaprim potent 49 commercialize deforolimus ARIAD 49 Lob Levyt 49 biomarker assay development 49 Endeavor DES 49 TMC# C# 49 DNAWitness Mito 49 Pfizer Selzentry 49 neural crest stem cell 49 Onno van de Stolpe 49 ANCHOR trial 49 SpermCheck 49 Drug Candidate 49 Preclinical Models 49 phase III isavuconazole 49 TACI Ig 49 Telintra 49 Inc. Nasdaq INFI 49 pandemic influenza strain 49 diphtheria tetanus pertussis 49 RECORD1 49 myoblast therapy 49 hepatitis B immunization 49 Bexion 49 Urnovitz 49 SIMPADICO 49 Pivotal Phase II 49 OHR/AVR# 49 Phase IIB 49 labial herpes 49 iii GTx 49 ADAGIO study 49 PDE# inhibitors 49 Retroscreen 49 seroprotection 48 EndoTAG TM -1 48 ResponseDX ™ 48 COMFORT II 48 RSD# oral 48 Psoriasis Drug 48 Demonstrates Positive 48 initiate Phase 2b 48 double blinded randomized 48 meningococcal conjugate vaccine 48 indications Cytokinetics 48 FluMist nasal flu 48 recombinant enzyme 48 Pneumococcal 48 quadrivalent vaccine 48 Ophena 48 3M Integrated Cycler 48 meningococcal conjugate 48 Raloxifene STAR 48 ONTARGET 48 Rezonic 48 identifier NCT# 48 Fluad 48 shingles vaccine Zostavax 48 EDEMA3 48 dose escalation trial 48 MChip 48 Avise PG 48 BufferGel 48 M2 inhibitors 48 BEZ# 48 DCVax ® Brain 48 Rheumatoid Arthritis Drug 48 randomized Phase IIb 48 PRESEPT study 48 abiraterone 48 mGluR5 antagonists 48 RNA amplification 48 AspirinWorks 48 hematological indications 48 MDS AML 48 SinoFresh Nasal Spray 48 diagnostic biomarker 48 latent tuberculosis TB 48 AVI antiviral programs 48 pentavalent vaccine 48 via intradermal injections 48 Curaxin 48 SPRIX ® 48 ocrelizumab 48 multi analyte 48 ILLUMINATE 48 e2 Collector 48 Preclinical Efficacy 48 viral tropism 48 Kinase inhibitors 48 midstage studies 48 vaccine Cervarix 48 including eniluracil ADH 48 metastatic hormone refractory 48 vascular disrupting agent 48 ASSERT trial 48 Antibody Drug Conjugate 48 randomized Phase III 48 valent vaccine 48 patented DepoVax TM 48 ENDEAVOR II 48 Phase 2a clinical 48 pneumococcal conjugate 48 inactivated polio vaccine 48 Rosetta Genomics microRNA 48 hMPV 48 Hyphanox 48 BLyS specific 48 AMPK activators 48 Ixiaro 48 TOCOSOL Paclitaxel 48 tumor immunology 48 CLARITY study 48 HPV cervical cancer 48 DiabeCell R 48 poliovirus vaccine 48 European Sepsis Trial 48 Teflaro 48 IQ OQ PQ 48 administered intramuscularly 48 VIAject ™ 48 multicenter randomized clinical 48 Onko Sure ™ 48 bicifadine 48 Serological 48 Rahul Singhvi 48 HCV RESPOND 2 48 microbicide trials 48 epothilone KOS 48 Wadih Arap 48 Romidepsin 48 APTIMA 48 Live Attenuated Influenza Vaccine 48 Avastin Tarceva 48 MAXY VII 48 Lu AA# 48 FM VP4 48 diptheria tetanus 48 Smallpox vaccine 48 EmbraceAC 48 Infanrix 48 Aurora Kinase 48 tetanus diptheria 48 Jean Pierre Routy 48 IMPACT DCM 48 Pentacel 48 quadrivalent human papillomavirus 48 HCV SPRINT 48 BSL3 48 Phase 1b Clinical Trial 48 Neo Bladder Augment 48 AIM HIGH 48 nonvaccine 48 iCardiac 48 oral poliovirus 48 Novartis Tasigna 48 Ragweed Allergy 48 microdose 48 Cannabinor 48 acellular pertussis 48 radiolabeling 48 dissolving microneedles 48 IIa trial 48 PEDIARIX 48 MenC 48 Measles Mumps 48 VaxAmerica 48 multicenter randomized placebo controlled 48 Pentacel vaccine 48 BREVAGen ™ 48 FLUARIX 48 ovarian cancer chronic hepatitis 48 non adjuvanted vaccine 48 exome capture 48 AN# novel 48 bluetongue vaccine 48 TG MV 48 PFO migraine 48 PPSV# 48 RE MODEL 48 fluoroquinolone resistant 48 Orville G. Kolterman 48 Intermittent Preventive Treatment 48 RapidResponse TM 48 Initiated Phase 48 Phase 2b kidney transplant 48 Dose escalation 48 Nucleic acid 48 vaccine Menveo 48 Aptamer 48 Oxytrex TM 48 Aurora kinase inhibitors 48 Dx TM 48 anti JCV antibody 47 Detection Kit 47 BC SeraPro 47 PROLARIS 47 Affinitak 47 Al Luderer Ph.D. 47 telomerase activator 47 nonclinical studies 47 SRT# [003] 47 Alfimeprase 47 PEARL SC 47 CAMMS# 47 pafuramidine maleate 47 randomized controlled multicenter 47 acellular pertussis DTaP 47 purity potency 47 ZOSTAVAX 47 Neo Kidney Augment 47 ACV1 47 Cambridge Biostability 47 injectible vaccine 47 clinical trials 47 trastuzumab emtansine T DM1 47 commercialize OncoGenex lead 47 Ankara MVA 47 Alastair Compston 47 Hep B vaccine 47 PEG irinotecan 47 Ebola Zaire 47 Cholesterol Levels SPARCL 47 molecular chaperone regulator 47 rotavirus vaccine RotaTeq 47 SCENESSE ® 47 MyVax personalized immunotherapy 47 SIgN 47 multitargeted 47 Phase IIa 47 humoral responses 47 Panvax 47 trivalent vaccine 47 Kotloff 47 Vitro Diagnostic IVD 47 Monica Mita 47 monovalent 47 Phase 2b trial 47 Phase IIB clinical 47 Pivotal Trials 47 Zeda Rosenberg 47 Xpert GBS 47 tezampanel NGX# 47 pertussis tetanus 47 Rubella MMR 47 ECVAM 47 forensicGEM TM 47 Phase IIb trials 47 protein kinase inhibitors 47 RiVax ™ 47 phase 2a 47 SEQureDx TM 47 trivalent flu 47 Roche AmpliChip 47 teplizumab 47 DCVax ® 47 Bevasiranib 47 antitumour 47 Dr O'Hallahan 47 revaccinate according 47 Acellular Pertussis 47 Novartis NVS Snapshot Report 47 Human Monoclonal Antibodies 47 GRN# 47 neutralizing antibody titers 47 CURRENT OASIS 7 47 olanzapine LAI 47 phenotyping 47 HIV1 47 DAPT 47 Val HeFT 47 varicella zoster virus VZV 47 Drug Fails 47 non O# STEC 47 antibody titers 47 OBPM 47 motavizumab 47 Di Bisceglie 47 intranasal insulin product 47 VITROS R 47 valopicitabine 47 PSN# [002] 47 Renata Pasqualini 47 AIDSVAX 47 inactivated flu 47 Epeius Biotechnologies Corporation 47 clinically differentiated 47 multicenter phase 47 Burkhard Phone 47 Rotarix R 47 Aptocine 47 VARIVAX 47 serologic testing 47 intranasal vaccine 47 Verigene System 47 Cylene 47 multicenter Phase 47 DIABECELL ® 47 AFREZZA ® 47 AVN# Phase 47 lipid nanoparticle LNP 47 anti infective medicines 47 IMPACT DCM clinical 47 placebo controlled multicenter 47 Memryte 47 vac cine 47 PCV2 47 MGMT methylation 47 Selzentry maraviroc 47 careHPV test 47 EFP weapon 47 vitro maturation IVM